<!DOCTYPE html>
<html>
<head>
    <title>PressReader - The Straits Times: 2020-08-29 - About the writ&#xAD;ers</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20200829/282222308143392" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>About the writ&#xAD;ers</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20200829/textview" title="The Straits Times - 2020-08-29"><time>2020-08-29</time></a>
        - <span>SCIENCE</span>
        - <span role="byline"></span>
    </section>

    <p>Dr An­to­nio Ber­to­letti is an ex­pert in in­fec­tious dis­eases who has made piv­otal con­tri­bu­tions to the un­der­stand­ing of T cell re­sponse to the hepatitis B virus. His re­search ca­reer has spanned The Scripps Re­search In­sti­tute in the United States, the Uni­ver­sity of Parma in Italy, Uni­ver­sity Col­lege of Lon­don, and the Agency for Science, Tech­nol­ogy and Re­search (A*Star). He is cur­rently pro­fes­sor and prin­ci­pal in­ves­ti­ga­tor for the Emerg­ing In­fec­tious Dis­eases pro­gramme at Duke-NUS Med­i­cal School, and co-founder of LionTCR, a biotech­nol­ogy com­pany fo­cused on the de­vel­op­ing T cell ther­apy against vi­ral in­fec­tions and vi­ral-re­lated can­cers.</p>
    <p>Dr Alessan­dra Nardin has more than 25 years of in­ter­na­tional ex­pe­ri­ence in im­munother­apy and vac­cine devel­op­ment in aca­demic and biotech en­vi­ron­ments in the US (Uni­ver­sity of Vir­ginia), France (IDM Pharma) and Sin­ga­pore (A*Star). Dr Nardin is co-founder and chief op­er­at­ing of­fi­cer of ImmunoScap­e, a Sin­ga­pore and US-based startup spe­cial­is­ing in deep pro­fil­ing of im­mune cells.</p>


</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
